157 related articles for article (PubMed ID: 15465348)
1. Conformationally-restricted vigabatrin analogs as irreversible and reversible inhibitors of gamma-aminobutyric acid aminotransferase.
Pan Y; Calvert K; Silverman RB
Bioorg Med Chem; 2004 Nov; 12(21):5719-25. PubMed ID: 15465348
[TBL] [Abstract][Full Text] [Related]
2. New substrates and inhibitors of gamma-aminobutyric acid aminotransferase containing bioisosteres of the carboxylic acid group: design, synthesis, and biological activity.
Yuan H; Silverman RB
Bioorg Med Chem; 2006 Mar; 14(5):1331-8. PubMed ID: 16263300
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological activity of a difluoro-substituted, conformationally rigid vigabatrin analogue as a potent gamma-aminobutyric acid aminotransferase inhibitor.
Pan Y; Qiu J; Silverman RB
J Med Chem; 2003 Dec; 46(25):5292-3. PubMed ID: 14640537
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and evaluation of fluorinated conformationally restricted analogues of GABA as potential inhibitors of GABA aminotransferase.
Wang Z; Silverman RB
Bioorg Med Chem; 2006 Apr; 14(7):2242-52. PubMed ID: 16314106
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rabbit brain 4-aminobutyrate transaminase by some taurine analogues: a kinetic analysis.
Ricci L; Frosini M; Gaggelli N; Valensin G; Machetti F; Sgaragli G; Valoti M
Biochem Pharmacol; 2006 May; 71(10):1510-9. PubMed ID: 16540097
[TBL] [Abstract][Full Text] [Related]
6. Inactivation and inhibition of gamma-aminobutyric acid aminotransferase by conformationally restricted vigabatrin analogues.
Choi S; Silverman RB
J Med Chem; 2002 Sep; 45(20):4531-9. PubMed ID: 12238932
[TBL] [Abstract][Full Text] [Related]
7. Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase.
Choi S; Storici P; Schirmer T; Silverman RB
J Am Chem Soc; 2002 Feb; 124(8):1620-4. PubMed ID: 11853435
[TBL] [Abstract][Full Text] [Related]
8. Active site model for gamma-aminobutyrate aminotransferase explains substrate specificity and inhibitor reactivities.
Toney MD; Pascarella S; De Biase D
Protein Sci; 1995 Nov; 4(11):2366-74. PubMed ID: 8563634
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.
Lu H; Silverman RB
J Med Chem; 2006 Dec; 49(25):7404-12. PubMed ID: 17149870
[TBL] [Abstract][Full Text] [Related]
10. Inhibition and substrate activity of conformationally rigid vigabatrin analogues with gamma-aminobutyric acid aminotransferase.
Qiu J; Pingsterhaus JM; Silverman RB
J Med Chem; 1999 Nov; 42(22):4725-8. PubMed ID: 10579835
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of unbound and aminooxyacetate-bound Escherichia coli gamma-aminobutyrate aminotransferase.
Liu W; Peterson PE; Carter RJ; Zhou X; Langston JA; Fisher AJ; Toney MD
Biochemistry; 2004 Aug; 43(34):10896-905. PubMed ID: 15323550
[TBL] [Abstract][Full Text] [Related]
12. Effects of GABA-transaminase inhibitor Vigabatrin on thermoregulation in rats.
Nikolov RP; Yakimova KS
Amino Acids; 2011 May; 40(5):1441-5. PubMed ID: 20878340
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of cyclopropane isosteres of the antiepilepsy drug vigabatrin and evaluation of their inhibition of GABA aminotransferase.
Wang Z; Silverman RB
J Enzyme Inhib Med Chem; 2004 Aug; 19(4):293-301. PubMed ID: 15558944
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Inactivation of GABA Aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic Acid.
Lee H; Le HV; Wu R; Doud E; Sanishvili R; Kellie JF; Compton PD; Pachaiyappan B; Liu D; Kelleher NL; Silverman RB
ACS Chem Biol; 2015 Sep; 10(9):2087-98. PubMed ID: 26110556
[TBL] [Abstract][Full Text] [Related]
15. [Acute psychosis and vigabatrin in childhood].
Chiaretti A; Castorina M; Tortorolo L; Piastra M; Polidori G
Pediatr Med Chir; 1994; 16(5):489-90. PubMed ID: 7885961
[TBL] [Abstract][Full Text] [Related]
16. 2,6-Difluorophenol as a bioisostere of a carboxylic acid: bioisosteric analogues of gamma-aminobutyric acid.
Qiu J; Stevenson SH; O'Beirne MJ; Silverman RB
J Med Chem; 1999 Jan; 42(2):329-32. PubMed ID: 9925739
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulations of apo, holo, and inactivator bound GABA-at reveal the role of active site residues in PLP dependent enzymes.
Gökcan H; Monard G; Sungur Konuklar FA
Proteins; 2016 Jul; 84(7):875-91. PubMed ID: 26800298
[TBL] [Abstract][Full Text] [Related]
18. Elevated endogenous GABA level correlates with decreased fMRI signals in the rat brain during acute inhibition of GABA transaminase.
Chen Z; Silva AC; Yang J; Shen J
J Neurosci Res; 2005 Feb; 79(3):383-91. PubMed ID: 15619231
[TBL] [Abstract][Full Text] [Related]
19. Structural modifications of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid, a potent irreversible inhibitor of GABA aminotransferase.
Yuan H; Silverman RB
Bioorg Med Chem Lett; 2007 Mar; 17(6):1651-4. PubMed ID: 17267220
[TBL] [Abstract][Full Text] [Related]
20. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.
Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS
Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
